Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma

Although the receptor tyrosine kinase (RTK) MET is widely expressed in head and neck squamous cell carcinoma (HNSCC), its prognostic value remains unclear. This might be due to the use of a variety of antibodies and scoring systems. Here, the reliability of five commercial C-terminal MET antibodies...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: De Herdt, Maria J., Willems, Stefan M., van der Steen, Berdine, Noorlag, Rob, Verhoef, Esther I., van Leenders, Geert J.L.H., van Es, Robert J.J., Koljenović, Senada, de Jong, Robert J. Baatenburg, Looijenga, Leendert H.J.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4914349/
https://ncbi.nlm.nih.gov/pubmed/26909606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7534
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados